Riot Platforms (RIOT) Competitors $12.15 -0.12 (-0.98%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends RIOT vs. VIVO, OSTK, OXFD, AWH, SOFI, ALLY, UWMC, BSAC, WF, and CIBShould you be buying Riot Platforms stock or one of its competitors? The main competitors of Riot Platforms include Meridian Bioscience (VIVO), Overstock.com (OSTK), Oxford Immunotec Global (OXFD), Aspira Women's Health (AWH), SoFi Technologies (SOFI), Ally Financial (ALLY), UWM (UWMC), Banco Santander-Chile (BSAC), Woori Financial Group (WF), and Bancolombia (CIB). Riot Platforms vs. Meridian Bioscience Overstock.com Oxford Immunotec Global Aspira Women's Health SoFi Technologies Ally Financial UWM Banco Santander-Chile Woori Financial Group Bancolombia Meridian Bioscience (NASDAQ:VIVO) and Riot Platforms (NASDAQ:RIOT) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, community ranking, institutional ownership and dividends. Which has better earnings & valuation, VIVO or RIOT? Meridian Bioscience has higher revenue and earnings than Riot Platforms. Riot Platforms is trading at a lower price-to-earnings ratio than Meridian Bioscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMeridian Bioscience$333.02M4.49$42.46M$0.9735.02Riot Platforms$280.70M14.38-$49.47M$1.518.05 Do analysts prefer VIVO or RIOT? Riot Platforms has a consensus target price of $16.35, suggesting a potential upside of 34.57%. Given Riot Platforms' stronger consensus rating and higher possible upside, analysts clearly believe Riot Platforms is more favorable than Meridian Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Meridian Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Riot Platforms 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Which has more risk and volatility, VIVO or RIOT? Meridian Bioscience has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Comparatively, Riot Platforms has a beta of 4.08, indicating that its share price is 308% more volatile than the S&P 500. Does the MarketBeat Community believe in VIVO or RIOT? Riot Platforms received 203 more outperform votes than Meridian Bioscience when rated by MarketBeat users. Likewise, 68.29% of users gave Riot Platforms an outperform vote while only 48.69% of users gave Meridian Bioscience an outperform vote. CompanyUnderperformOutperformMeridian BioscienceOutperform Votes31648.69% Underperform Votes33351.31% Riot PlatformsOutperform Votes51968.29% Underperform Votes24131.71% Do insiders and institutionals believe in VIVO or RIOT? 89.7% of Meridian Bioscience shares are owned by institutional investors. Comparatively, 40.3% of Riot Platforms shares are owned by institutional investors. 2.3% of Meridian Bioscience shares are owned by insiders. Comparatively, 6.9% of Riot Platforms shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is VIVO or RIOT more profitable? Riot Platforms has a net margin of 115.35% compared to Meridian Bioscience's net margin of 12.70%. Meridian Bioscience's return on equity of 16.74% beat Riot Platforms' return on equity.Company Net Margins Return on Equity Return on Assets Meridian Bioscience12.70% 16.74% 13.09% Riot Platforms 115.35%14.89%14.01% Does the media refer more to VIVO or RIOT? In the previous week, Riot Platforms had 3 more articles in the media than Meridian Bioscience. MarketBeat recorded 3 mentions for Riot Platforms and 0 mentions for Meridian Bioscience. Riot Platforms' average media sentiment score of 0.88 beat Meridian Bioscience's score of 0.00 indicating that Riot Platforms is being referred to more favorably in the news media. Company Overall Sentiment Meridian Bioscience Neutral Riot Platforms Positive SummaryRiot Platforms beats Meridian Bioscience on 14 of the 19 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get Riot Platforms News Delivered to You Automatically Sign up to receive the latest news and ratings for RIOT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RIOT vs. The Competition Export to ExcelMetricRiot PlatformsNondepository credit institutions IndustryBusiness SectorNASDAQ ExchangeMarket Cap$4.04B$8.04B$6.93B$8.82BDividend YieldN/A5.19%2.92%4.07%P/E Ratio8.0516.6846.0917.74Price / Sales14.3815.55203.9474.25Price / Cash12.6042.0424.3332.53Price / Book1.332.555.084.68Net Income-$49.47M$462.43M$121.42M$226.08M7 Day Performance-4.10%-0.27%-1.11%-2.03%1 Month Performance23.23%24.94%8.17%0.07%1 Year Performance7.33%107.16%29.60%24.61% Riot Platforms Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RIOTRiot Platforms4.1524 of 5 stars$12.15-1.0%$16.35+34.6%+7.3%$4.08B$312.91M8.05340Insider TradeGap UpVIVOMeridian Bioscience1.0351 of 5 stars$33.97flatN/AN/A$1.50B$333.02M35.02702Analyst ForecastOSTKOverstock.comN/AN/AN/AN/A$760.30M$1.93B-4.671,050Gap UpOXFDOxford Immunotec GlobalN/A$21.99flatN/AN/A$570.90M$73.71M-439.80273Analyst ForecastAWHAspira Women's Health1.5354 of 5 stars$0.73+2.8%$4.40+502.7%-78.5%$11.44M$9.15M0.00110Analyst ForecastGap UpSOFISoFi Technologies2.423 of 5 stars$14.67+1.7%$9.80-33.2%+121.8%$15.65B$2.12B146.714,400Analyst ForecastALLYAlly Financial4.977 of 5 stars$35.53-0.1%$40.69+14.5%+28.6%$10.83B$8.21B14.2111,100UWMCUWM2.9797 of 5 stars$6.07-2.7%$7.53+24.1%+7.0%$9.97B$1.31B0.006,700Options VolumeBSACBanco Santander-Chile4.2727 of 5 stars$19.52+1.3%$21.50+10.1%+1.7%$9.08B$6.07B11.099,229Positive NewsWFWoori Financial Group3.8453 of 5 stars$35.44+0.6%N/A+20.5%$8.72B$17.78B4.61150CIBBancolombia1.4595 of 5 stars$33.49+1.7%$33.67+0.5%+21.9%$7.92B$27.76T5.3134,756Positive News Related Companies and Tools Related Companies VIVO Alternatives OSTK Alternatives OXFD Alternatives AWH Alternatives SOFI Alternatives ALLY Alternatives UWMC Alternatives BSAC Alternatives WF Alternatives CIB Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RIOT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Riot Platforms, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Riot Platforms With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.